Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

GPT HEALTHCARE LTD. 2023-24 Annual Report Analysis
Wed, 3 Jul

GPT HEALTHCARE LTD. has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

GPT HEALTHCARE LTD. Income Statement Analysis

  • Operating income during the year rose 10.8% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 18.1% YoY during the fiscal. Operating profit margins witnessed a fall and down at 21.9% in FY24 as against 20.6% in FY23.
  • Depreciation charges increased by 20.6% and finance costs decreased by 22.5% YoY, respectively.
  • Other income declined by 7.1% YoY.
  • Net profit for the year grew by 22.5% YoY.
  • Net profit margins during the year grew from 10.8% in FY23 to 11.9% in FY24.

GPT HEALTHCARE LTD. Income Statement 2023-24

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Net Sales Rs m 3,610 4,002 10.8%
Other income Rs m 57 53 -7.1%
Total Revenues Rs m 3,667 4,055 10.6%
Gross profit Rs m 744 878 18.1%
Depreciation Rs m 149 180 20.6%
Interest Rs m 92 71 -22.5%
Profit before tax Rs m 560 680 21.6%
Tax Rs m 170 203 19.5%
Profit after tax Rs m 390 478 22.5%
Gross profit margin % 20.6 21.9
Effective tax rate % 30.3 29.8
Net profit margin % 10.8 11.9
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Must See: These Segments are Witnessing Incredible Growth with Modi's Push

GPT HEALTHCARE LTD. Balance Sheet Analysis

  • The company's current liabilities during FY24 down at Rs 772 million as compared to Rs 818 million in FY23, thereby witnessing an decrease of -5.7%.
  • Long-term debt down at Rs 36 million as compared to Rs 403 million during FY23, a fall of 91.0%.
  • Current assets fell 1% and stood at Rs 802 million, while fixed assets rose 8% and stood at Rs 3 billion in FY24.
  • Overall, the total assets and liabilities for FY24 stood at Rs 3 billion as against Rs 3 billion during FY23, thereby witnessing a growth of 6%.

GPT HEALTHCARE LTD. Balance Sheet as on March 2024

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Networth Rs m 1,654 2,185 32.1
 
Current Liabilities Rs m 818 772 -5.7
Long-term Debt Rs m 403 36 -91.0
Total Liabilities Rs m 3,268 3,455 5.7
 
Current assets Rs m 813 802 -1.4
Fixed Assets Rs m 2,455 2,654 8.1
Total Assets Rs m 3,268 3,455 5.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



GPT HEALTHCARE LTD. Cash Flow Statement Analysis

  • GPT HEALTHCARE LTD.'s cash flow from operating activities (CFO) during FY24 stood at Rs 688 million, an improvement of 3.7% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY24 stood at Rs -252 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY24 stood at Rs -485 million, an improvement of 34% on a YoY basis.
  • Overall, net cash flows for the company during FY24 stood at Rs -49 million from the Rs -17 million net cash flows seen during FY23.

GPT HEALTHCARE LTD. Cash Flow Statement 2023-24

Particulars No. of months 12 12 % Change
Year Ending Mar-23 Mar-24
Cash Flow from Operating Activities Rs m 664 688 3.7%
Cash Flow from Investing Activities Rs m 52 -252 -
Cash Flow from Financing Activities Rs m -732 -485 -
Net Cash Flow Rs m -17 -49 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for GPT HEALTHCARE LTD.

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 5.8, an improvement from the EPS of Rs 4.9 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 156.5, stands at 26.9 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 5.9 times, while the price to sales ratio stands at 3.2 times.
  • The company's price to cash flow (P/CF) ratio stood at 22.4 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Sales per share (Unadj.) Rs 45.2 48.8
TTM Earnings per share Rs 4.9 5.8
Diluted earnings per share Rs 4.8 5.8
Price to Cash Flow x 0.0 22.4
TTM P/E ratio x 0.0 26.9
Price / Book Value ratio x 0.0 6.7
Market Cap Rs m 0 14,741
Dividends per share (Unadj.) Rs 4.0 3.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for GPT HEALTHCARE LTD.

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 1.0x during FY24, from 1.0x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 10.6x during FY24, from 7.1x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 21.9% during FY24, from 23.6% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 33.8% during FY24, from 31.7% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 15.9% during FY24, from 14.7% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Current ratio x 1.0 1.0
Debtors’ Days Days 209 221
Interest coverage x 7.1 10.6
Debt to equity ratio x 0.2 0.0
Return on assets % 14.7 15.9
Return on equity % 23.6 21.9
Return on capital employed % 31.7 33.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how GPT HEALTHCARE LTD. has performed over the last 5 years, please visit here.

GPT HEALTHCARE LTD. Share Price Performance

Over the last one year, GPT HEALTHCARE LTD. share price has moved up from Rs 0.0 to Rs 156.5, registering a gain of Rs 156.5 or around 0.0%.

Overall, the S&P BSE SENSEX is up 22.5% over the year.

(To know more, check out historical annual results for GPT HEALTHCARE LTD. and quarterly results for GPT HEALTHCARE LTD.)

Annual Report FAQs

What is the current share price of GPT HEALTHCARE LTD.?

GPT HEALTHCARE LTD. currently trades at Rs 164.2 per share. You can check out the latest share price performance of GPT HEALTHCARE LTD. here...

What was the revenue of GPT HEALTHCARE LTD. in FY24? How does it compare to earlier years?

The revenues of GPT HEALTHCARE LTD. stood at Rs 4,055 m in FY24, which was up 10.6% compared to Rs 3,667 m reported in FY23.

GPT HEALTHCARE LTD.'s revenue has grown from Rs 2,161 m in FY20 to Rs 4,055 m in FY24.

Over the past 5 years, the revenue of GPT HEALTHCARE LTD. has grown at a CAGR of 17.0%.

What was the net profit of GPT HEALTHCARE LTD. in FY24? How does it compare to earlier years?

The net profit of GPT HEALTHCARE LTD. stood at Rs 478 m in FY24, which was up 22.5% compared to Rs 390 m reported in FY23.

This compares to a net profit of Rs 417 m in FY22 and a net profit of Rs 211 m in FY21.

Over the past 5 years, GPT HEALTHCARE LTD. net profit has grown at a CAGR of 44.5%.

What does the cash flow statement of GPT HEALTHCARE LTD. reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of GPT HEALTHCARE LTD. reveals:

  • Cash flow from operations increased in FY24 and stood at Rs 688 m as compared to Rs 664 m in FY23.
  • Cash flow from investments decreased in FY24 and stood at Rs -252 m as compared to Rs 52 m in FY23.
  • Cash flow from financial activity increased in FY24 and stood at Rs -485 m as compared to Rs -732 m in FY23.

Here's the cash flow statement of GPT HEALTHCARE LTD. for the past 5 years.

(Rs m)FY20FY21FY22FY23FY24
From Operations415430660664688
From Investments-543-165-5352-252
From Financial Activity119-221-572-732-485
Net Cashflow-94435-17-49

What does the Key Ratio analysis of GPT HEALTHCARE LTD. reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of GPT HEALTHCARE LTD. reveals:

  • Operating profit margins witnessed a fall and down at 21.9% in FY24 as against 20.6% in FY23.
  • Net profit margins grew from 10.8% in FY23 to 11.9% in FY24.
  • Debt to Equity ratio for FY24 stood at 0.0 as compared to 0.2 in FY23.

Here's the ratio/financial analysis of GPT HEALTHCARE LTD. for the past 5 years.

 FY20FY21FY22FY23FY24
Operating Profit Margin (%)16.920.221.920.621.9
Net Profit Margin (%)5.28.712.310.811.9
Debt to Equity Ratio (x)0.80.80.50.20.0

Equitymaster requests your view! Post a comment on "GPT HEALTHCARE LTD. 2023-24 Annual Report Analysis". Click here!